- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Bortezomib, Melphalan, Prednisone, Thalidomide
Total 221 results
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaIsrael, Czechia, United States, Germany, Spain, Japan, United Kingdom, France, Brazil
-
PETHEMA FoundationActive, not recruitingNewly Diagnosed Multiple MyelomaSpain
-
University of LouisvilleJames Graham Brown Cancer CenterWithdrawn
-
University of CincinnatiMillennium Pharmaceuticals, Inc.Completed
-
Azienda Socio Sanitaria Territoriale degli Spedali...CompletedHIV Infections | HIV-related LymphomaItaly
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Mayo ClinicWithdrawnMultiple Myeloma | Refractory Multiple Myeloma
-
Oncopeptides ABTerminatedMultiple MyelomaUnited States, France, Spain, Czechia
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Intergroupe Francophone du MyelomeUnknown
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia | Loss of Chromosome 17p | Autologous Hematopoietic Stem Cell Transplant RecipientUnited States
-
University of ArkansasMillennium Pharmaceuticals, Inc.Active, not recruitingMultiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
PETHEMA FoundationJanssen-Cilag Ltd.; Mundipharma Pharmaceuticals B.V.Completed
-
Peking UniversityUnknownGlomerulonephritis, IGA
-
University Hospital, LilleAmgenUnknown
-
AmgenCompletedMultiple MyelomaGreece, Italy, Netherlands
-
Janssen Scientific Affairs, LLCCompletedMultiple MyelomaAustralia, China, Korea, Republic of
-
Nantes University HospitalCompleted
-
Riverside Haematology GroupUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Guangdong Provincial People's HospitalRecruitingImmunoglobulin Light-Chain AmyloidosisChina
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
Nantes University HospitalCompleted
-
Boston Medical CenterTerminatedAL AmyloidosisUnited States
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
Lymphoma Trials OfficeUnknownLymphomaUnited Kingdom, Denmark, Norway, Czech Republic
-
Universitätsklinikum Hamburg-EppendorfGemeinsamer Bundesausschuss (G-BA); Staburo GmbHRecruiting
-
University Hospital Plymouth NHS TrustCompleted
-
Fondazione EMN Italy OnlusCompleted
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed Follicular LymphomaUnited States, Puerto Rico
-
Commissie Voor Klinisch Toegepast OnderzoekUnknownMultiple Myeloma and Plasma Cell NeoplasmNetherlands, Belgium
-
University of MiamiWithdrawnMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Boston Medical CenterMillennium Pharmaceuticals, Inc.Completed
-
University Hospital Southampton NHS Foundation...Janssen-Cilag Ltd.CompletedLymphoma, Large B-Cell, DiffuseUnited Kingdom, Switzerland
-
Children's Cancer Group, ChinaXiangya Hospital of Central South University; Qilu Hospital of Shandong University and other collaboratorsRecruitingT-cell Lymphoblastic LymphomaChina
-
Seoul National University HospitalSeoul National University Bundang HospitalUnknownWaldenstrom Macroglobulinemia | Lymphoplasmacytic LymphomaKorea, Republic of
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Spain
-
University of ArkansasJanssen, LPActive, not recruitingMultiple MyelomaUnited States
-
University of ArkansasActive, not recruitingUARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Terminated
-
European Myeloma NetworkEMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Greece, Italy
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited Kingdom, Spain, Canada, United States, Czechia
-
CelgeneMultiple Myeloma Research ConsortiumCompleted
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
PETHEMA FoundationCompleted
-
PETHEMA FoundationCelgene; Pierre Fabre Medicament; Janssen, LPCompleted
-
Henrik GregersenUnknown
-
Fondazione EMN Italy OnlusActive, not recruitingMultiple Myeloma | Newly Diagnosed PatientsItaly
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCompleted